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T cells Figure 6 . ShK inhibits Type 1 diabetes autoantigen-specific CD4 and CD8 T cell proliferation. a. CD4 + and CD8 + T cell gating strategy. Live lymphocyte gate was set based on forward scatter (FSC) vs. side scatter (SSC). CD4 + and CD8 + gates were then set based on CD4 and CD8 expression, respectively. PBMC from HLA-DR4 + T1D donors were stimulated with a combination of HLA-DR4-restricted GAD65 peptides (b, n = 10 biological replicates) in the absence or presence of either 10 nM ShK or 1 µM TRAM-34, or PBMC from non-HLA-or HLA-typed T1D donors were stimulated with GAD65 protein (c, n = 13 biological replicates). Proliferation responses were determined at day 7 by CFSE dilution of CD4 + -or CD8 + -gated cells. Representative data from one donor are shown. Percentages indicated in red denote % reduction in proliferation relative to vehicle-treated cells. 
